MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$118,933
-55.6%
198,288
-3.7%
0.00%
Q2 2023$267,651
-27.8%
205,885
-2.3%
0.00%
Q1 2023$370,894
-45.5%
210,735
-2.7%
0.00%
Q4 2022$680,416
-66.8%
216,693
-48.2%
0.00%
-100.0%
Q3 2022$2,051,000
+188.5%
418,562
+242.0%
0.00%
Q1 2022$711,000
-21.7%
122,387
+1.0%
0.00%
Q4 2021$908,000
+82.7%
121,133
+119.7%
0.00%
Q3 2021$497,00055,1350.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders